This is an unusual issue -- one third of the papers concern process evaluation, investigating interventions that have been evaluated in other analyses and papers, one third concern data collection tools (measures/assessments), and only one third concern evaluation of interventions. When an intervention is subject to evaluation in a trial, it is helpful to know to what extent the intervention was carried out as planned, and/or to what extent it caused the expected immediate change that, in principle at least, finally benefits the patient. A programme to teach self-management to patients after stroke, 'Plan Ahead!' has been evaluated and, unfortunately in some respects, it was found not to benefit patients. The paper published here may explain whether this was due to poor implementation, or because self-management is not effective. Reading it will answer this question, but note that high patient satisfaction with an intervention did not mean that it was effective (service commissioners, please note!). A randomized trial of occupational therapy delivered at home to people with Parkinson's disease did show benefit, statistically significant, but only one third of patients benefited. The process evaluation here identified several aspects of the intervention that needed improvement, mostly related to managing complexity and the patient's particular needs. A third evaluation published investigated whether training clinicians to be client-centred achieved this goal. Again the primary analysis did not find any patient benefit from training therapists to be client-centred -- why not? The process study finds that clinicians did become more client-centred. This needs further research to understand why not benefit was found. I am generally reluctant to support the development of new data-collection tools -- there are thousands already available -- but the PRECiS is an exception; it is a patient reported evaluation of cognitive state and its initial evaluation is published in this issue. I am in favour of testing and improving existing scales, and a second study in this issue evaluates the Geriatric Anxiety Inventory as a tool to detect anxiety after stroke; it has reasonably good credentials and may be an advance on the widely used Hospital Anxiety and Depression Scale. I particularly like studies that are large scale and introduce me (and hopefully others) to a measure of a concept not previously known to me. The third study is large (n = 737 people with rheumatoid arthritis) and covers an important domain, valued life activities. The authors suggest that it could be a good measure of social participation, in the context of the biopsychosocial model of illness. Back to evaluating interventions. A feasibility, pilot study of group treatment to improve adjustment to having multiple sclerosis (n = 21) found it may be feasible, but attendance is not good. A second relatively small trial (n = 38) investigated whether inspiratory muscle training would improve function in people with atrial fibrillation; it appears to improve both respiratory function and, more importantly, walking endurance. It needs a larger study to conform this. Last, a systematic review of seven trials and 886 participants found that exercise does reduce pain and increase function in people with hip osteoarthritis but that the evidence concerning manual therapy either alone or in combination was weak.
